ArticleJournal of ovarian research2026
CBX2 promotes cisplatin resistance in ovarian cancer via SIAH2-mediated β-catenin stabilization and ATG9B-dependent autophagy activation.
Xinxin Kou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.